Monoclonal antibodies are lab-made copies of the naturally occurring antibodies that defend the body against pathogens and foreign substances. Invented on 7 August 1975, by Georges Kohler and Cesar Milstein1, they have transformed science and health care with their ability to detect and target specific antigens, making them workhorses in many research laboratories and a major tool for diagnostics and therapy.

In therapeutic monoclonal antibody service, mAbs are used to neutralize cancer cells while sparing healthy tissue, and can be further modified into chimeric antibodies or antibody-drug conjugates for direct tumor killing. Their wide-ranging utility is rooted in their ability to capture and interact with a diverse range of targets, from soluble proteins like cytokines and hormones to membrane-bound structures such as receptors and kinases.

When selecting a monoclonal antibody service, technical expertise and experience should be top considerations. Look for a partner that can provide a streamlined process from conceptualization to delivery, and a track record of successfully producing high-quality, custom monoclonal antibodies with a wide range of applications.

IHC CRO Services Explained: How Contract Labs Support Your Research

A reliable monoclonal antibody service should be able to deliver highly-characterized, robust antibodies that can be validated across multiple methods such as Western blot, ELISA, immunohistochemistry and flow cytometry. It should also be able to offer customization capabilities, such as isotype switching and humanization, for optimal cross-application performance. Lastly, it should prioritize access to cutting-edge AI tools for fast optimizations and automated workflows. These include protein expression platforms such as CHO and baculovirus, as well as GenOptimizer, the world’s most advanced gene optimization platform developed by Thermo Scientific.

…